Page 143 - Restamax Plc Annual Report 2017
P. 143

CASH FLOW STATEMENT FOR 1 JANUARY–31 DECEMBER 2017


               € thousand                                      1 January–31 December 2017  1 January–31 December 2016
               Operating cash flow:
               Profit (loss) before appropriations and taxes                    1,807                  1,888
               Adjustments:
               Scheduled depreciations and impairment                           1,758                  2,028
               Other income and expenses that do not incur payments              -54                   -889
               Financial income and expenses                                   -1,470                  -755
               Other adjustments                                                 -307                    83
               Cash flow before change in working capital                       1,734                  2,355
               Change in working capital:
               Increase (-)/deduction (+) in current interest-free receivables  -1170                   319
               Increase (-)/deduction (+) in inventories                         -187                    21
               Increase (-)/deduction (+) in current interest-free liabilities   1914                  -948
               Operating cash flow before financial items and taxes             2,291                  1,746
               Interest and fees paid for other operating finance costs          -755                  -757
               Dividends received from business operations                      1,233                  1,516
               Interest received from business operations                         151                   896
               Immediate taxes paid                                            -1,636                 -1,914
               Cash flow before extraordinary items                             1,285                  1,488
               Operating cash flow (A)                                          1,285                 1,488
               Investment cash flow:
               Investments in tangible and intangible assets                   -4,709                  -984
               Income from assignment of tangible and intangible assets           55                   1,082
               Investments in other investments                                -4,367                  -779
               Income from assignment of other investments                       199                     0
               Deduction (+)/increase (-) of non-current loans receivable      -2,826                 -2,245
               Investment cash flow: (B)                                      -11,649                -2,926
               Finance cash flow:
               Current loans drawn (+)/repaid (-)                               3,565                 -1,367
               Non-current loans drawn (+)                                      13,560                21,740
               Non-current loans repaid (-)                                    -7,673                -20,960
               Dividends paid and other distribution of profits                -4,986                 -4,368
               Group contributions received (+)                                 6,162                  6,424
               Group contributions given (-)                                     -159                    0
               Finance cash flow: (C)                                          10,469                 1,469
               Change in cash and cash equivalents (A+B+C),                      105                     30
               increase (+)/deduction (-)
               Cash and cash equivalents at the beginning of the financial period  315                  158
                  Cash and cash equivalents transferred in merger                  0                    126
               Cash and cash equivalents at the end of the financial period       421                   315
               Cash and cash equivalents at the end of the financial period,      105                    30
               excluding the merger
                  Change                                                           0                     0




















                                                               EMOYHTIÖN TILINPÄÄTÖS (FAS)                        143
   138   139   140   141   142   143   144   145   146   147   148